Recalls / Active ingredient / Cefazolin Sodium
Cefazolin Sodium
6 FDA drug recalls involving the active ingredient “Cefazolin Sodium” — 3 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-06-27 | Class I | Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only, Manufac | Sandoz Inc |
| 2022-04-13 | Class II | Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-13 | Class II | Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun M | Mckesson Medical-Surgical Inc. Corporate Office |
| 2021-03-15 | Class II | Cefazolin for Injection, USP 1 gram per vial Rx Only Single-use Vial Sterile Manufactured in Austria by Sandoz | Cardinal Health Inc. |
| 2013-11-21 | Class I | Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-1 | B. Braun Medical Inc |
| 2013-11-21 | Class I | Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103- | B. Braun Medical Inc |